Ticker: CO, Company: China Cord Blood Corp, Type: SC TO-I/A, Date: 2010-12-13
Original SEC Filing: Click here
Webplus: CO/20101213/SC_TO-I.A/1/000.htm SEC Original: v205334_sctoia.htm
_____________HEDULE TO (Amendment No. 2) _____________ (Rule 14d-100) Tender Offer Statement under Section14(d)(1) or 13(e)(1) _____________ CHINARD BLOODRPORATION (Name of Subjectmpany (Issuer) and Name of Filing Person (Issuer)) (Title of Class of Securities)G211071181 _____________________ ) _____________bert Chen +852 3605 8180bert.chen@chinacordbloodcorp.com 48th Floor, Bank of China Tower
Webplus: CO/20101213/SC_TO-I.A/2_EX-99.A.5.F/000.htm SEC Original: v205334_ex99a5f.htm
HONG KONG, China, December 13, – Chinard Bloodrporation Ms. Ting Zheng, Chairperson and CEO of Chinard Bloodrporationmmented, We believe shareholders will appreciate our simplifiedpital structure.With no further dilution, shareholders will fully enjoy the benefits of our operational accomplishments and robust growth, even on a per share basis.Withl the stakeholders interests now fullyigned, we willntinue to
Company Information:
Ticker: CO, Company: China Cord Blood Corp, Type: SC TO-I/A, Date: 2010-12-13CIK: 0001467808, Location: K3, SIC: 6770, SIC Desc: BLANK CHECKS
Business Phone & Address:
48 FL., BANK OF CHINA TOWER, 1 GARDEN ROAD
CENTRAL HONG KONG, K3 000000
-
- Forum
- Topics
- Last Post
Leave A Comment
You must be logged in to post a comment.